Role of mass spectrometry-based proteomics in the study of cellular reprogramming and induced pluripotent stem cells

Expert Review of Proteomics

Volumn 9, Issue 4, 2012, Pages 379-399

  Benevento, Marco ^a,b   Munoz, Javier ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS PROTEOMICS CENTRE   (Netherlands)

Author keywords

embryonic stem cells; epigenomics; induced pluripotent stem cells; proteomics; transcriptomics

Indexed keywords

HISTONE H3; KRUPPEL LIKE FACTOR 4; MICRORNA; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2; UNTRANSLATED RNA;

ADULT STEM CELL; AUTOTRANSPLANTATION; BIODIVERSITY; BLASTOCYST; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; COPY NUMBER VARIATION; CYTOPLASM; DNA METHYLATION; EMBRYONIC STEM CELL; EPIGENETICS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENOME ANALYSIS; HISTONE MODIFICATION; MALIGNANT TRANSFORMATION; MASS SPECTROMETRY; MICROARRAY ANALYSIS; NONHUMAN; OOCYTE; PLURIPOTENT STEM CELL; PROTEIN PROCESSING; PROTEOMICS; REGENERATIVE MEDICINE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL TRANSPLANTATION; TRANSPOSON; TROPHOBLAST;

CELL DIFFERENTIATION; CELL NUCLEUS; DNA COPY NUMBER VARIATIONS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MASS SPECTROMETRY; MICRORNAS; NUCLEAR REPROGRAMMING; PROTEOMICS; REGENERATIVE MEDICINE; RNA, UNTRANSLATED; TRANSCRIPTION, GENETIC;

EID: 84866310097     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.12.30     Document Type: Review

References (158)

1. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 292(5819), 154-156 (1981). (Pubitemid 11050741)
2. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 282(5391), 1145-1147 (1998). (Pubitemid 28516247)
3. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat. Biotechnol. 18(4), 399-404 (2000). (Pubitemid 30217526)
4. Zarzeczny A, Caulfield T. Emerging ethical, legal and social issues associated with stem cell research & and the current role of the moral status of the embryo. Stem Cell Rev. 5(2), 96-101 (2009).
5. Hyun I. The bioethics of stem cell research and therapy. J. Clin. Invest. 120(1), 71-75 (2010).
6. Gurdon JB. Changes in somatic cell nuclei inserted into growing and maturing amphibian oocytes. J. Embryol. Exp. Morphol. 20(3), 401-414 (1968).
7. Willadsen SM. Nuclear transplantation in sheep embryos. Nature 320(6057), 63-65 (1986). (Pubitemid 16105246)
8. Wilmut I, Beaujean N, de Sousa PA et al. Somatic cell nuclear transfer. Nature 419(6907), 583-586 (2002).
9. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4), 663-676 (2006). (Pubitemid 44233629)
10. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5), 861-872 (2007). (Pubitemid 350138099)
11. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858), 1917-1920 (2007).
12. Park IH, Zhao R, West JA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451(7175), 141-146 (2008).
13. Loh YH, Agarwal S, Park IH et al. Generation of induced pluripotent stem cells from human blood. Blood 113(22), 5476-5479 (2009).
14. Eminli S, Utikal J, Arnold K, Jaenisch R, Hochedlinger K. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells 26(10), 2467-2474 (2008).
15. Hanna J, Markoulaki S, Schorderet P et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133(2), 250-264 (2008). (Pubitemid 351508307)
16. Hockemeyer D, Soldner F, Cook EG, Gao Q, Mitalipova M, Jaenisch R. A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell 3(3), 346-353 (2008).
17. Woltjen K, Michael IP, Mohseni P et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458(7239), 766-770 (2009).
18. Kim D, Kim CH, Moon JI et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4(6), 472-476 (2009).
19. Miyoshi N, Ishii H, Nagano H et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 8(6), 633-638 (2011).
20. Wu SM, Hochedlinger K. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat. Cell Biol. 13(5), 497-505 (2011).
21. Hanna J, Wernig M, Markoulaki S et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318(5858), 1920-1923 (2007).
22. Wernig M, Zhao JP, Pruszak J et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl Acad. Sci. USA 105(15), 5856-5861 (2008). (Pubitemid 351758462)
23. Maehr R, Chen S, Snitow M et al. Generation of pluripotent stem cells from patients with Type 1 diabetes. Proc. Natl Acad. Sci. USA 106(37), 15768-15773 (2009).
24. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120(5), 408-416 (2009).
25. Ebert AD, Yu J, Rose FF Jr et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457(7227), 277-280 (2009).
26. Ben-Nun IF, Montague SC, Houck ML et al. Induced pluripotent stem cells from highly endangered species. Nat. Methods 8(10), 829-831 (2011).
27. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132(4), 567-582 (2008). (Pubitemid 351253686)
28. Feng Q, Lu SJ, Klimanskaya I et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28(4), 704-712 (2010).
29. Hu BY, Weick JP, Yu J et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl Acad. Sci. USA 107(9), 4335-4340 (2010).
30. Chin MH, Mason MJ, Xie W et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5(1), 111-123 (2009).
31. Chin MH, Pellegrini M, Plath K, Lowry WE. Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell 7(2), 263-269 (2010).
32. Guenther MG, Frampton GM, Soldner F et al. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7(2), 249-257 (2010).
33. Newman AM, Cooper JB. Lab-specific gene expression signatures in pluripotent stem cells. Cell Stem Cell 7(2), 258-262 (2010).
34. Boyer LA, Lee TI, Cole MF et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122(6), 947-956 (2005). (Pubitemid 41345211)
35. Müller FJ, Laurent LC, Kostka D et al. Regulatory networks define phenotypic classes of human stem cell lines. Nature 455(7211), 401-405 (2008).
36. Polo JM, Liu S, Figueroa ME et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 28(8), 848-855 (2010).
37. Ohi Y, Qin H, Hong C et al. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol. 13(5), 541-549 (2011).
38. Berger SL. The complex language of chromatin regulation during transcription. Nature 447(7143), 407-412 (2007). (Pubitemid 46816746)
39. Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 10(5), 295-304 (2009).
40. Kafri T, Ariel M, Brandeis M et al. Developmental pattern of gene-specific DNA methylation in the mouse embryo and germ line. Genes Dev. 6(5), 705-714 (1992).
41. Loh YH, Yang L, Yang JC, Li H, Collins JJ, Daley GQ. Genomic approaches to deconstruct pluripotency. Annu. Rev. Genomics Hum. Genet. 12, 165-185 (2011).
42. Stadler MB, Murr R, Burger L et al. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 480(7378), 490-495 (2011).
43. Deng J, Shoemaker R, Xie B et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat. Biotechnol. 27(4), 353-360 (2009).
44. Doi A, Park IH, Wen B et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 41(12), 1350-1353 (2009).
45. Kim K, Doi A, Wen B et al. Epigenetic memory in induced pluripotent stem cells. Nature 467(7313), 285-290 (2010).
46. Kim K, Zhao R, Doi A et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat. Biotech. 29(12), 1117-1119 (2011).
47. Bock C, Kiskinis E, Verstappen G et al. Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144(3), 439-452 (2011).
48. Lister R, Pelizzola M, Kida YS et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471(7336), 68-73 (2011).
49. Hawkins RD, Hon GC, Lee LK et al. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 6(5), 479-491 (2010).
50. Bernstein BE, Kamal M, Lindblad-Toh K et al. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120(2), 169-181 (2005). (Pubitemid 40174761)
51. Boyer LA, Plath K, Zeitlinger J et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441(7091), 349-353 (2006). (Pubitemid 44050199)
52. Bernstein BE, Mikkelsen TS, Xie X et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125(2), 315-326 (2006).
53. Pan G, Tian S, Nie J et al. Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell 1(3), 299-312 (2007). (Pubitemid 47355329)
54. Akkers RC, van Heeringen SJ, Jacobi UG et al. A hierarchy of H3K4me3 and H3K27me3 acquisition in spatial gene regulation in Xenopus embryos. Dev. Cell 17(3), 425-434 (2009
55. Schuettengruber B, Ganapathi M, Leblanc B et al. Functional anatomy of polycomb and trithorax chromatin landscapes in Drosophila embryos. PLoS Biol. 7(1), e13 (2009).
56. Mikkelsen TS, Hanna J, Zhang X et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 454(7200), 49-55 (2008). (Pubitemid 351931978)
57. Wellner U, Schubert J, Burk UC et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemnessinhibiting microRNAs. Nat. Cell Biol. 11(12), 1487-1495 (2009).
58. Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137(4), 647-658 (2009).
59. Samavarchi-Tehrani P, Golipour A, David L et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 7(1), 64-77 (2010).
60. Subramanyam D, Lamouille S, Judson RL et al. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat. Biotechnol. 29(5), 443-448 (2011).
61. Anokye-Danso F, Trivedi CM, Juhr D et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8(4), 376-388 (2011).
62. Wilson KD, Venkatasubrahmanyam S, Jia F, Sun N, Butte AJ, Wu JC. MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev. 18(5), 749-758 (2009).
63. Maitra A, Arking DE, Shivapurkar N et al. Genomic alterations in cultured human embryonic stem cells. Nat. Genet. 37(10), 1099-1103 (2005). (Pubitemid 41486662)
64. Baker DE, Harrison NJ, Maltby E et al. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 25(2), 207-215 (2007). (Pubitemid 46227120)
65. Hussein SM, Batada NN, Vuoristo S et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471(7336), 58-62 (2011).
66. Laurent LC, Ulitsky I, Slavin I et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8(1), 106-118 (2011).
67. Gore A, Li Z, Fung HL et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 471(7336), 63-67 (2011).
68. Schwanhäusser B, Busse D, Li N et al. Global quantification of mammalian gene expression control. Nature 473(7347), 337-342 (2011).
69. Nilsson T, Mann M, Aebersold R, Yates JR 3rd, Bairoch A, Bergeron JJ. Mass spectrometry in high-throughput proteomics: Ready for the big time. Nat. Methods 7(9), 681-685 (2010).
70. Cox J, Mann M. Quantitative, highresolution proteomics for data-driven systems biology. Annu. Rev. Biochem. 80, 273-299 (2011).
71. Witze ES, Old WM, Resing KA, Ahn NG. Mapping protein post-translational modifications with mass spectrometry. Nat. Methods 4(10), 798-806 (2007). (Pubitemid 350055576)
72. Whetton AD, Williamson AJ, Krijgsveld J et al. The time is right: proteome biology of stem cells. Cell Stem Cell 2(3), 215-217 (2008).
73. Lu R, Markowetz F, Unwin RD et al. Systems-level dynamic analyses of fate change in murine embryonic stem cells. Nature 462(7271), 358-362 (2009).
74. Pardo M, Lang B, Yu L et al. An expanded Oct4 interaction network: Implications for stem cell biology, development, and disease. Cell Stem Cell 6(4), 382-395 (2010).
75. van den Berg DL, Snoek T, Mullin NP et al. An Oct4-centered protein interaction network in embryonic stem cells. Cell Stem Cell 6(4), 369-381 (2010).
76. Van Hoof D, Dormeyer W, Braam SR et al. Identification of cell surface proteins for antibody-based selection of human embryonic stem cell-derived cardiomyocytes. J. Proteome Res. 9(3), 1610-1618 (2010).
77. Bendall SC, Hughes C, Campbell JL et al. An enhanced mass spectrometry approach reveals human embryonic stem cell growth factors in culture. Mol. Cell Proteomics 8(3), 421-432 (2009).
78. Zoumaro-Djayoon AD, Ding V, Foong L-Y, Choo A, Heck AJR, Muñoz J. Investigating the role of FGF-2 in stem cell maintenance by global phosphoproteomics profiling. Proteomics 11(20), 3962-3971 (2011).
79. Brill LM, Xiong W, Lee KB et al. Phosphoproteomic analysis of human embryonic stem cells. Cell Stem Cell 5(2), 204-213 (2009).
80. Van Hoof D, Muñoz J, Braam SR et al. Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell 5(2), 214-226 (2009).
81. Rigbolt KT, Prokhorova TA, Akimov V et al. System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci. Signal. 4(164), rs3 (2011).
82. Brumbaugh J, Rose CM, Phanstiel DH, Thomson JA, Coon JJ. Proteomics and pluripotency. Crit. Rev. Biochem. Mol. Biol. 46(6), 493-506 (2011).
83. Reiland S, Salekdeh GH, Krijgsveld J. Defining pluripotent stem cells through quantitative proteomic analysis. Expert Rev. Proteomics 8(1), 29-42 (2011).
84. Munoz J, Low TY, Kok YJ et al. The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells. Mol. Syst. Biol. 7, 550 (2011).
85. Phanstiel DH, Brumbaugh J, Wenger CD et al. Proteomic and phosphoproteomic comparison of human ES and iPS cells. Nat. Methods 8(10), 821-827 (2011).
86. Kim SY, Kim M-J, Jung H et al. Comparative proteomic analysis of human somatic cells, induced pluripotent stem cells, and embryonic stem cells. Stem Cells Dev. 21(18), 1272-1286 (2011).
87. Huang X, Tian C, Liu M et al. Quantitative proteomic analysis of mouse embryonic fibroblasts and induced pluripotent stem cells using 16O/18O labeling. J. Proteome Res. 11(4), 2091-2102 (2012).
88. Ross PL, Huang YN, Marchese JN et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using aminereactive isobaric tagging reagents. Mol. Cell Proteomics 3(12), 1154-1169 (2004).
89. Boersema PJ, Raijmakers R, Lemeer S, Mohammed S, Heck AJ. Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. Nat. Protoc. 4(4), 484-494 (2009).
90. Pinkse MW, Mohammed S, Gouw JW, van Breukelen B, Vos HR, Heck AJ. Highly robust, automated, and sensitive online TiO2-based phosphoproteomics applied to study endogenous phosphorylation in Drosophila melanogaster. J. Proteome Res. 7(2), 687-697 (2008). (Pubitemid 351294031)
91. Gauci S, Helbig AO, Slijper M, Krijgsveld J, Heck AJ, Mohammed S. Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal. Chem. 81(11), 4493-4501 (2009).
92. Frese CK, Altelaar AF, Hennrich ML et al. Improved peptide identification by targeted fragmentation using CID, HCD and ETD on an LTQ-Orbitrap Velos. J. Proteome Res. 10(5), 2377-2388 (2011).
93. Van Hoof D, Pinkse MW, Oostwaard DW, Mummery CL, Heck AJ, Krijgsveld J. An experimental correction for arginine-to-proline conversion artifacts in SILAC-based quantitative proteomics. Nat. Methods 4(9), 677-678 (2007). (Pubitemid 47338150)
94. Bendall SC, Hughes C, Stewart MH, Doble B, Bhatia M, Lajoie GA. Prevention of amino acid conversion in SILAC experiments with embryonic stem cells. Mol. Cell Proteomics 7(9), 1587-1597 (2008).
95. Graumann J, Hubner NC, Kim JB et al. Stable isotope labeling by amino acids in cell culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5,111 proteins. Mol. Cell Proteomics 7(4), 672-683 (2008). (Pubitemid 351597479)
96. Pichler P, Köcher T, Holzmann J et al. Peptide labeling with isobaric tags yields higher identification rates using iTRAQ 4-plex compared to TMT 6-plex and iTRAQ 8-plex on LTQ Orbitrap. Anal. Chem. 82(15), 6549-6558 (2010).
97. Ting L, Rad R, Gygi SP, Haas W. MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics. Nat. Meth. 8(11), 937-940 (2011).
98. Wenger CD, Lee MV, Hebert AS et al. Gasphase purification enables accurate, multiplexed proteome quantification with isobaric tagging. Nat. Meth. 8(11), 933-935 (2011).
99. Balgley BM, Laudeman T, Yang L, Song T, Lee CS. Comparative evaluation of tandem MS search algorithms using a target-decoy search strategy. Mol. Cell Proteomics 6(9), 1599-1608 (2007). (Pubitemid 47506170)
100. Claassen M, Reiter L, Hengartner MO, Buhmann JM, Aebersold R. Generic comparison of protein inference engines. Mol. Cell Proteomics. 11(4), O110.007088 (2011).
101. Beck M, Schmidt A, Malmstroem J et al. The quantitative proteome of a human cell line. Mol. Syst. Biol. 7, 549 (2011).
102. Nagaraj N, Wisniewski JR, Geiger T et al. Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7, 548 (2011).
103. Gabut M, Samavarchi-Tehrani P, Wang X et al. An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell 147(1), 132-146 (2011).
104. Mercer TR, Gerhardt DJ, Dinger ME et al. Targeted RNA sequencing reveals the deep complexity of the human transcriptome. Nat. Biotechnol. 30(1), 99-104 (2012).
105. Baek D, Villén J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 455(7209), 64-71 (2008).
106. Selbach M, Schwanhäusser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 455(7209), 58-63 (2008).
107. Mallanna SK, Ormsbee BD, Iacovino M et al. Proteomic analysis of Sox2-associated proteins during early stages of mouse embryonic stem cell differentiation identifies Sox21 as a novel regulator of stem cell fate. Stem Cells 28(10), 1715-1727 (2010).
108. Wang J, Rao S, Chu J et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 444(7117), 364-368 (2006). (Pubitemid 44764111)
109. Schnütgen F, Ehrmann F, Poser I et al. Resources for proteomics in mouse embryonic stem cells. Nat. Methods 8(2), 103-104 (2011).
110. Ng HH, Surani MA. The transcriptional and signalling networks of pluripotency. Nat. Cell Biol. 13(5), 490-496 (2011).
111. Ying QL, Nichols J, Chambers I, Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115(3), 281-292 (2003). (Pubitemid 37487702)
112. Vallier L, Alexander M, Pedersen RA. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell. Sci. 118(Pt 19), 4495-4509 (2005). (Pubitemid 41556347)
113. Xu RH, Peck RM, Li DS, Feng X, Ludwig T, Thomson JA. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat. Methods 2(3), 185-190 (2005). (Pubitemid 41122125)
114. Pera MF, Andrade J, Houssami S et al. Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin. J. Cell. Sci. 117(Pt 7), 1269-1280 (2004). (Pubitemid 38456107)
115. Xu RH, Chen X, Li DS et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat. Biotechnol. 20(12), 1261-1264 (2002). (Pubitemid 35462493)
116. Greenow K, Clarke AR. Controlling the stem cell compartment and regeneration in vivo: The role of pluripotency pathways. Physiol. Rev. 92(1), 75-99 (2012).
117. Silva J, Barrandon O, Nichols J, Kawaguchi J, Theunissen TW, Smith A. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 6(10), e253 (2008).
118. Woltjen K, Stanford WL. Preview. Inhibition of TGF-b signaling improves mouse fibroblast reprogramming. Cell Stem Cell 5(5), 457-458 (2009).
119. Marson A, Foreman R, Chevalier B et al. Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 3(2), 132-135 (2008).
120. Choudhary C, Mann M. Decoding signalling networks by mass spectrometrybased proteomics. Nat. Rev. Mol. Cell Biol. 11(6), 427-439 (2010).
121. Huttlin EL, Jedrychowski MP, Elias JE et al. A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143(7), 1174-1189 (2010).
122. Choudhary C, Kumar C, Gnad F et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325(5942), 834-840 (2009).
123. Xu G, Paige JS, Jaffrey SR. Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling. Nat. Biotech. 28(8), 868-873 (2010).
124. Zielinska DF, Gnad F, Wisniewski JR, Mann M. Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell 141(5), 897-907 (2010).
125. Yamanaka S. Elite and stochastic models for induced pluripotent stem cell generation. Nature 460(7251), 49-52 (2009).
126. Wernig M, Lengner CJ, Hanna J et al. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat. Biotechnol. 26(8), 916-924 (2008).
127. Markoulaki S, Hanna J, Beard C et al. Transgenic mice with defined combinations of drug-inducible reprogramming factors. Nat. Biotechnol. 27(2), 169-171 (2009).
128. Altschuler SJ, Wu LF. Cellular heterogeneity: Do differences make a difference? Cell 141(4), 559-563 (2010).
129. Raj A, Rifkin SA, Andersen E, van Oudenaarden A. Variability in gene expression underlies incomplete penetrance. Nature 463(7283), 913-918 (2010).
130. Hanna J, Saha K, Pando B et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462(7273), 595-601 (2009).
131. Altelaar AM, Heck AJ. Trends in ultrasensitive proteomics. Curr. Opin. Chem. Biol. 16(1-2), 206-213 (2012).
132. Di Palma S, Stange D, van de Wetering M, Clevers H, Heck AJ, Mohammed S. Highly sensitive proteome analysis of FACS-sorted adult colon stem cells. J. Proteome Res. 10(8), 3814-3819 (2011).
133. Seet BT, Dikic I, Zhou MM, Pawson T. Reading protein modifications with interaction domains. Nat. Rev. Mol. Cell Biol. 7(7), 473-483 (2006). (Pubitemid 44036453)
134. Young NL, Dimaggio PA, Garcia BA. The significance, development and progress of high-throughput combinatorial histone code analysis. Cell. Mol. Life Sci. 67(23), 3983-4000 (2010).
135. Tan M, Luo H, Lee S et al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 146(6), 1016-1028 (2011).
136. Sakabe K, Wang Z, Hart GW. β-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc. Natl Acad. Sci. USA 107(46), 19915-19920 (2010).
137. Mikesh LM, Ueberheide B, Chi A et al. The utility of ETD mass spectrometry in proteomic analysis. Biochim. Biophys. Acta 1764(12), 1811-1822 (2006). (Pubitemid 44895029)
138. Young NL, DiMaggio PA, Plazas-Mayorca MD, Baliban RC, Floudas CA, Garcia BA. High throughput characterization of combinatorial histone codes. Mol. Cell Proteomics 8(10), 2266-2284 (2009).
139. Phanstiel D, Brumbaugh J, Berggren WT et al. Mass spectrometry identifies and quantifies 74 unique histone H4 isoforms in differentiating human embryonic stem cells. Proc. Natl Acad. Sci. USA 105(11), 4093-4098 (2008). (Pubitemid 351754340)
140. Tian Z, Zhao R, Tolic N et al. Twodimensional liquid chromatography system for online top-down mass spectrometry. Proteomics 10(20), 3610-3620 (2010).
141. Vermeulen M, Eberl HC, Matarese F et al. Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers. Cell 142(6), 967-980 (2010).
142. Bartels SJ, Spruijt CG, Brinkman AB, Jansen PW, Vermeulen M, Stunnenberg HG. A SILAC-based screen for Methyl CpG binding proteins identifies RBP-J as a DNA methylation and sequence-specific binding protein. PLoS ONE 6(10), e25884 (2011).
143. Muller F-J, Schuldt BM, Williams R et al. A bioinformatic assay for pluripotency in human cells. Nat. Meth. 8(4), 315-317 (2011).
144. Picotti P, Bodenmiller B, Mueller LN, Domon B, Aebersold R. Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell 138(4), 795-806 (2009).
145. de Graaf EL, Altelaar AF, van Breukelen B, Mohammed S, Heck AJ. Improving SRM assay development: A global comparison between triple quadrupole, ion trap, and higher energy CID peptide fragmentation spectra. J. Proteome Res. 10(9), 4334-4341 (2011).
146. MacArthur BD, Lachmann A, Lemischka IR, Ma'ayan A. GATE: Software for the analysis and visualization of highdimensional time series expression data. Bioinformatics 26(1), 143-144 (2010).
147. Baker M. Quantitative data: Learning to share. Nat. Meth. 9(1), 39-41 (2012).
148. Park IH, Arora N, Huo H et al. Diseasespecific induced pluripotent stem cells. Cell 134(5), 877-886 (2008).
149. Rashid ST, Corbineau S, Hannan N et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J. Clin. Invest. 120(9), 3127-3136 (2010).
150. Yahata N, Asai M, Kitaoka S et al. Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease. PLoS ONE 6(9), e25788 (2011).
151. Schirle M, Bantscheff M, Kuster B. Mass spectrometry-based proteomics in preclinical drug discovery. Chem. Biol. 19(1), 72-84 (2012).
152. Carr SA, Anderson L. Protein quantitation through targeted mass spectrometry: The way out of biomarker purgatory? Clin. Chem. 54(11), 1749-1752 (2008).
153. Marchetto MC, Yeo GW, Kainohana O, Marsala M, Gage FH, Muotri AR. Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One 4(9), e7076 (2009).
154. Ghosh Z, Wilson KD, Wu Y, Hu S, Quertermous T, Wu JC. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One 5(2), e8975 (2010).
155. Stadtfeld M, Apostolou E, Akutsu H et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465(7295), 175-181 (2010).
156. Mayshar Y, Ben-David U, Lavon N et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7(4), 521-531 (2010).
157. Neveu P, Kye MJ, Qi S, Buchholz DE et al. MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states. Cell Stem Cell 7(6), 671-681 (2010).
158. Nishino K, Toyoda M, Yamazaki-Inoue M et al. Defining hypo-methylated regions of stem cell-specific promoters in human iPS cells derived from extra-embryonic amnions and lung fibroblasts. PLoS One 5(9), e13017 (2010).